Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Links
Dow Jones Industrial Average
) is trading down 49.0 points (-0.3%) at 15,493 as of Thursday, Jul 25, 2013, 9:35 a.m. ET. During this time, 21.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 589.7 million. The NYSE advances/declines ratio sits at 819 issues advancing vs. 1,725 declining with 150 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 14-cent gain (+0.1%) bringing the stock to $96.80. Volume for McDonald's Corporation currently sits at 137,889 shares traded vs. an average daily trading volume of 5.1 million shares.
McDonald's Corporation has a market cap of $97.01 billion and is part of the services sector and leisure industry. Shares are up 9.7% year to date as of Wednesday's close. The stock's dividend yield sits at 3.2%.
McDonald's Corporation franchises and operates McDonald's restaurants in the United States, Europe, the Asia/Pacific, the Middle East, Africa, Canada, and Latin America. Its restaurants offer various food items, soft drinks, coffee, and other beverages, as well as breakfast menus.
TheStreet Ratings rates McDonald's Corporation as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and increase in stock price during the past year. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
- You can view the full McDonald's Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with a 44-cent decline (-1.5%) bringing the stock to $28.84. This single loss is lowering the Dow Jones Industrial Average by 3.33 points or roughly accounting for 6.8% of the Dow's overall loss. Volume for Pfizer currently sits at 2.1 million shares traded vs. an average daily trading volume of 63 million shares.
Pfizer has a market cap of $207.88 billion and is part of the health care sector and drugs industry. Shares are up 17.3% year to date as of Wednesday's close. The stock's dividend yield sits at 3.3%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Pfizer Ratings Report.